$Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists$

Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

Bibliographic Details
Main Authors:	Monica Carpenedo, Arianna Zappaterra, Beatrice Ferrari, Giulia Cotilli
Format:	Article
Language:	English
Published:	Mattioli1885 2023-02-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Chronic ITP ITP thrombopoietin new agents New Drugs Refractory ITP
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/5240

Similar Items

Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?
by: Jefri Pratama Susanto
Published: (2016-11-01)

Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
by: Alex Shimanovsky, et al.
Published: (2016-01-01)

Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice
by: V V PTUSHKIN, et al.
Published: (2018-07-01)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
by: Kensaku Nakai, et al.
Published: (2022-02-01)

Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis
by: Joyce Tumaini Massaro, et al.
Published: (2019-10-01)

Knowledge map of thrombopoietin receptor agonists: A bibliometric analysis
by: Rong Hu, et al.
Published: (2024-01-01)

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
by: Tsykunova G, et al.
Published: (2022-03-01)

Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review
by: Gian Marco Podda, et al.
Published: (2022-01-01)

Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists
by: Lamya Garabet, et al.
Published: (2020-02-01)

Immunomodulation in Primary Immune Thrombocytopenia: A Possible Role of the Fc Fragment of Romiplostim?
by: Alexandra Schifferli, et al.
Published: (2019-06-01)

Chronic immune thrombocytopenic purpura in children overview of 60 patients
by: Ahmed Hatem Sabhan, et al.
Published: (2016-05-01)

Parallel pathogens: Coexistence of chickenpox and idiopathic thrombocytopenic purpura—A case report
by: Abhigan Babu Shrestha, et al.
Published: (2023-10-01)

Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review
by: Simone Birocchi, et al.
Published: (2021-02-01)

Chemokine 12 plasma level in pediatric patients with Immune Thrombocytopenic purpura and its relation to Disease Activity
by: Gamal Eldin Taha, et al.
Published: (2022-04-01)

First report on health-related quality of life among children with chronic immune thrombocytopenia in Vietnam
by: Sang Ngoc Nguyen, PhD, et al.
Published: (2021-10-01)

Refractory immune thrombocytopenic purpura associated with IgM monoclonal gammopathy of undetermined significance: Successful treatment with tirabrutinib plus conventional therapies
by: Ryosuke Naka, et al.
Published: (2022-05-01)

Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature
by: Naser Al-Husban, et al.
Published: (2018-06-01)

Stimulation of platelet production: the new treatment approach to chronic immune thrombocytopenic purpura
by: A. A. Maschan, et al.
Published: (2022-11-01)

Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms
by: Claudia Cristina Tărniceriu, et al.
Published: (2022-02-01)

CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS
by: E. A. Pyadushkina, et al.
Published: (2016-02-01)

Romiplostim – an emergency treatment of intracranial haemorrhage in the course of severe primary immune thrombocytopaenia
by: Paweł Łaguna, et al.
Published: (2022-12-01)

Idiopathic thrombocytopenic purpura (ITP) – new era for an old disease
by: Onisâi Minodora, et al.
Published: (2019-12-01)

Immune Thrombocytopenic Purpura
by: Teny Tjitra Sari
Published: (2018-08-01)

Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)
by: Rick Kapur, et al.
Published: (2020-04-01)

The Outcome of Withholding Pharmacologic Treatment in Children with Acute ITP
by: Jalil I Alezzi, et al.
Published: (2019-10-01)

The Outcome of Withholding Pharmacologic Treatment in Children with Acute ITP
by: Jalil I Alezzi, et al.
Published: (2019-10-01)

Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association?
by: Maria L Lozano, et al.
Published: (2020-10-01)

Lifting the fog over ITP
by: Philip Young-Ill Choi
Published: (2020-04-01)

Endothelial alterations in a canine model of immune thrombocytopenia
by: Dana N. LeVine, et al.
Published: (2019-01-01)

Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy
by: Rui-jie Sun, et al.
Published: (2019-03-01)

Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia
by: Liu Xin-guang, et al.
Published: (2016-01-01)

PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC
by: Francesco Rodeghiero
Published: (2021-04-01)

Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
by: Bonnie J.B. Lewis, et al.
Published: (2021-11-01)

Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report
by: Martin Koch, et al.
Published: (2021-07-01)

Idiopathic Autoimmune Thrombocytopenic Purpura (ITP) in adult; review of 50 cases admitted to Baghdad teaching hospital.
by: Adil S. Al-Aqabi, et al.
Published: (2010-07-01)

A Survey of 121 patients with Idiopathic Thrombocytopenic Purpura
by: Shahriariahmadi A, et al.
Published: (2005-07-01)

A Survey of 121 patients with Idiopathic Thrombocytopenic Purpura
by: A Shahriariahmadi, et al.
Published: (2005-06-01)

Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content
by: Nuria Revilla, et al.
Published: (2019-08-01)

Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia
by: Jundong Zhang, et al.
Published: (2023-04-01)

Prognostic factors for positive immune thrombocytopenic purpura outcome after laparoscopic splenectomy
by: Kiudelis Mindaugas, et al.
Published: (2011-02-01)